Background: Evidence for risks of adverse maternal and birth outcomes in women with hyperemesis gravidarum (HG) is predominantly from small studies, unknown, or conflicting. Methods: A population-based cohort study using secondary health care records (Hospital Episode Statistics covering all of England from 1997 to 2012) was used to calculate odds ratios (OR) with 99% confidence intervals (CI) for the association between HG hospital admission and adverse outcomes, adjusting for maternal and pregnancy confounders. Results: Within 8 211 850 pregnancies ending in live births or stillbirths, women with HG had increased odds of anaemia (OR 1.28, 99% CI 1.23, 1.33), preeclampsia (OR 1.16, 99% CI 1.09, 1.22), eclampsia (OR 1.84, 99% CI 1.07, 3.18), venous thromboembolism antenatally (OR 1.94, 99% CI 1.57, 2.39 for deep vein thrombosis, and OR 2.54, 99% CI 1.89, 3.40 for pulmonary embolism) and post-partum. Odds of stillbirth (OR 0.77, 99% CI 0.66, 0.89) and post-term (OR 0.86, 99% CI 0.81, 0.92) delivery were decreased. Women were more likely to be induced (OR 1.20, 99% CI 1.16, 1.23), to deliver preterm (OR 1.11, 99% CI 1.05, 1.17), very preterm (OR 1.18, 99% CI 1.05, 1.32), or by caesarean section (OR 1.12, 99% CI 1.08, 1.16), to have low birthweight (OR 1.12, 99% CI 1.08, 1.17) or small for gestational age (OR 1.06, 99% CI 1.01, 1.11) babies and although absolute risks were small, their offspring were more likely to undergo resuscitation or neonatal intensive care. Conclusion: HG may have important antenatal and postnatal consequences that should be considered in communications between health care professionals and women to best manage HG and prevent progression during pregnancy.
Hyperemesis gravidarum (HG) is the most severe form of nausea and vomiting in pregnancy (NVP) and in many cases requires hospital admission and continuous treatment. 1 It affects up to 2% of pregnancies, causing other maternal and child morbidities responsible for further hospital admissions and adverse social, psychological, and economic impacts in affected women. 2 In England in 2010 alone, HG was the primary diagnosis for over 17 500 hospital admissions in pregnancy. 3 Whilst maternal dehydration, 1, 4, 5 weight loss, and anaemia 1 are the most evident consequences of HG, severe NVP can also trigger central nervous system complications, 4 liver and renal failure, 6 and venous thromboembolism (VTE). 7 There is some evidence of a higher risk of placental dysfunction and preeclampsia 8 in women first admitted with HG in the second trimester, whilst associations with complications such as gestational diabetes and hypertension [9] [10] [11] or postnatal VTE 12,13 are less clear. There is conflicting evidence on how HG may directly affect the health of the unborn child in terms of birthweight or being small-for-gestational-age. Although some studies suggest that HG is not associated with adverse pregnancy outcomes, 9, 10 others have found associations with preterm birth 14 and lower birthweight. 15, 16 Moreover, little evidence has been reported on the occurrence of stillbirth 8 and need for neonatal care for babies born to women affected by HG. The burden of HG likely remains grossly underestimated by the medical community 5 and urgent calls for large population studies on this topic have been raised. 17 We assessed the risk of adverse maternal, pregnancy, and birth outcomes for women admitted to hospital for HG, using a cohort of over 8 million pregnancies identified from anonymised electronic hospital records in England. Outcomes investigated included stillbirth, low birthweight, preterm birth, and delivery complications for both the mother and the baby.
Materials and methods

Study population
A cohort of pregnancies was built by extracting data on each delivery recorded in the English maternity Hospital Episode Statistics (HES) dataset between April 1997 and March 2011, including only pregnancies ending in live birth or stillbirth, as previously described. 3 A probabilistic matching algorithm was used to link a mother's delivery record to one or more children's birth records. A hierarchical approach used the following 6 variables in a priority order: delivery date, unique hospital identifier, postcode of residence, unique general practice identifier, gestational age at birth, and birthweight. Overall 86.3% of the total HES pregnancies were matched to one or more children. Of the matched pregnancies, 32.1% had a unique match to children on all variables, providing the highest degree of certainty; inability to match on all variables was mainly due to missing information primarily for gestation or birthweight in either the mother or child's record. The following 57.2% were matched on 4-5 variables. The remaining 10.7% were matched with the minimum requirement of the first 3 variables, still providing a robust assumption. Whilst our probability matching algorithm will have a margin of error we expect this to be small and this is a standard approach with routinely collected anonymised datasets for health research. 18, 19 HES data are anonymised such that individual patients as well as the location of residence cannot be identified by researchers. Ethical approval for this study was obtained from The Health & Social Care Information Centre (DSA Reference: DARS-NIC-25516-N5Q7T).
Hyperemesis gravidarum
A pregnancy was considered affected by HG if at least one admission with an ICD-10 code (International Classification of Diseases version 10, used to define diagnoses) for HG (O210 or O211) was recorded as the primary diagnosis, excluding admissions on the date of delivery, in line with a previous published study. 3 Pregnancies with a first admission for HG in the third trimester were excluded as HG usually peaks at 8 weeks' gestation and a later first admission could be a misdiagnosis of other pregnancy complications such as preeclampsia or acute fatty liver of pregnancy. 8 We grouped women as having only one HG admission during pregnancy (i.e. HG admission), having at least one readmission (i.e. HG readmission) or no HG admissions during pregnancy.
Adverse maternal, pregnancy, and birth outcomes
Outcomes were selected based on the literature 9, 14, 17 and availability in HES data. Maternal and pregnancy outcomes included birth status (live birth or stillbirth); gestational age at delivery grouped as very preterm (24-31 weeks), preterm (32-36 weeks), term (37-41 weeks) and post-term (over 42 weeks); type of delivery (spontaneous, assisted or breech extraction, emergency or elective caesarean section); haemorrhage (ante, intra, and post-partum); induction of labour (surgical, medical, both, unspecified); placental dysfunction (malformation, praevia, abruption); anaemia occurring after the first trimester; preeclampsia (with or without eclampsia); gestational diabetes; gestational hypertension; and venous thromboembolism (VTE) during pregnancy, at delivery and in the first 12 weeks post-partum, distinguishing between deep vein thrombosis (DVT) and pulmonary embolism (PE). Delivery and post-partum VTE analysis without history within the current pregnancy or delivery was also assessed to distinguish a first event from (previously treated) recurrences. The recorded prevalence of delivery type was comparable to published HES statistics 20 and other published work. 21 Comorbidities were extracted from diagnostic codes according to ICD-10 code lists and relevant procedures (e.g. caesarean section) from OPCS-4 codes (Office of Population Censuses and Surveys Classification of Interventions and Procedures, used to define procedures). The maternity HES dataset provided information whenever missing from the two previous sources. This priority reflects the ordered level of data quality, where procedure recording is expected to have the highest accuracy due to the original purpose of hospital data recording. Gestational age at birth, birthweight, neonatal care, and resuscitation are only available from maternity HES. Live births or stillbirths were obtained mainly from recorded diagnoses (97.5% for live outcomes and 97% for stillbirths) and then from maternity HES. Induction of labour was obtained in a priority order from recorded information on procedures from OPCS-4 used during delivery (85%) which were largely in agreement with the maternity HES dataset (except for surgical induction which was underreported in maternity HES), recorded ICD-codes (0.6%), and maternity HES (14%).
We assessed the following adverse birth outcomes amongst live matched singletons: need for neonatal care (special, intensive, and very intensive); resuscitation method (drugs, drugs and mask, tube, tube and drugs); birthweight (<2500, 2500-3999, and ≥4000 g). small for gestational age (SGA) or large for gestational age (LGA), defined as less than the 10th centile and more than the 90th centile, respectively, were estimated using the Global Reference standard that accounts for mean differences in birthweight by maternal race. 22, 23 Potential confounding factors identified a priori were those previously shown to be associated with HG as well as with adverse maternal and neonatal outcomes. 3 They were year of delivery, English region of secondary care setting, maternal age, parity, ethnicity, socio-economic group as measured by quintile of the Index of Multiple Deprivation (IMD 2010), maternal comorbidities (anaemia, thyroid and parathyroid dysfunctions, hypercholesterolemia, pre-existing diabetes, or hypertension), sex of the baby, and birth plurality. Details and methods to obtain these factors are described elsewhere. 3 
Statistical analysis
We calculated the percentage of pregnancies affected by HG hospital admission and readmission (as a proportion of all pregnancies) and assessed variation across different values of each outcome. For the binary outcomes gestational anaemia, diabetes, and hypertension, we performed logistic regression to estimate odds ratios (OR) with 99% confidence intervals (CI) for the associations with HG admission and HG readmission, both compared with a baseline of no admission. As all other maternal, pregnancy, or birth outcomes had three or more possibilities (e.g. low, normal, or high birthweight), we used multinomial logistic regression with the relative risk ratio (RRR) option in Stata to produce similar effect measures. The RRR is sometimes interpreted as a conditional odds ratio or called a multinomial odds ratio and so for the purposes of this paper we report model output as an OR from here forward. We applied a cluster correction to all analyses to account for potential clustering effects from women who had more than one pregnancy during the study period. Analyses were adjusted for maternal confounders and different sets of relevant outcomes other than the outcome under analysis, depending on the time of onset of the factor and the potential confounding effect that those outcomes could have in each risk assessment analysis (Table 1) . Standard adjustments: maternal age, maternal ethnicity, socioeconomic status, year of delivery, region of treatments, parity, preexisting anaemia, pre-existing and gestational diabetes, pre-existing and gestational hypertension, hypercholesterolemia, thyroid dysfunction, parathyroid dysfunction, sex of the baby, and plurality. Mutual indicates adjustment for other factors within the group (e.g. other antenatal complications). a Gestational diabetes or hypertension are not adjusted for the same pre-existing condition. Postnatal VTE was also adjusted for pregnancy outcome, induction of labour, gestational week at delivery, and mode of delivery.
Missing values for gestational age groups (32%) were imputed using an ordered logistic regression imputation method in Stata MPv14 (Stata Corp, College Station, TX) statistical package, with 10 imputed datasets and the predictor variables in Table 2 . Sensitivity analysis was also conducted excluding all pregnancies with missing information. A similar method was used to impute small-or large-forgestational-age.
Results
We obtained a cohort of 8 211 850 pregnancies from 5 329 101 women, where 0.53% (n = 43 766) of pregnancies ended in stillbirth, and 1.6% (n = 130 138) were multiple deliveries ( Table 2 ). The prevalence of HG admission and readmission was 1.02% (n = 83 679) and 0.42% (n = 34 518), respectively. The prevalence showed that hospital admission and readmission for HG were more common in women under the age of 30, of Black or Asian ethnicity, with higher socio-economic deprivation, carrying multiple babies or a female baby, and with pre-existing anaemia, thyroid or parathyroid dysfunction, hypercholesterolemia, or type 1 diabetes in the current pregnancy. Table 3 shows the numbers, proportions, and adjusted odds ratios for each adverse maternal outcome for women with one HG admission and HG readmission, compared to women without HG admissions. Compared with women from the referent group, women with one admission for HG had an increased relative odds of developing anaemia, pre eclampsia, and eclampsia during the current pregnancy. These women also showed an increased relative odds of antepartum VTE for DVT and for PE, VTE recorded during the delivery admission. A generally higher relative odds was shown for women with more than one admission for HG, particularly, for antepartum DVT and delivery and post-partum PE. Confidence intervals of effect estimates overlapped between HG admission and readmission for most outcomes, other than for anaemia and gestational hypertension, the odds of which were both higher for HG readmission.
Although the odds ratios for preeclampsia and VTE were high for admitted women, the absolute increased risks were generally low (absolute risks of preeclampsia were 2.2%, 2.7%, and 3.1% in women without HG admission, with HG admission and with readmission, respectively; for antepartum DVT absolute risks were 9, 18, and 25 per 10 000 pregnancies, respectively; for post-partum DVT absolute risks were 4, 6, and 7 per 10 000 pregnancies, respectively).
The adjusted analysis for adverse delivery outcomes (Table 4) showed a decreased relative odds of stillbirth (OR 0.77, 99% CI 0.66, 0.89), in pregnancies affected by a single admission for HG. There was not significant variation for haemorrhage and placental dysfunction, though elective caesarean section and induction of labour were more likely in women with HG (OR 1.12, 99% CI 1.08, 1.16 for caesarean section, OR 1.20, 99% CI 1.16, 1.23 for surgical and medical induction). Although the analyses of HG readmission were affected by limited statistical power, the results described above were largely similar.
The prevalence of HG admission and readmission and the distribution of maternal characteristics within the 6 835 060 singleton pregnancies were the same as for the whole population shown in Table 2 , indicating that the restricted matched population was not different from the original one. The risk of adverse birth outcome also varied between women with and without HG ( Table 5) . Women with a single admission for HG were more likely to deliver very preterm, preterm birth and less likely to deliver post-term. The relative odds of neonates being in need of resuscitation with drugs or drugs and mask, and intensive neonatal care were also higher. Moreover, babies from pregnancies affected by HG were more likely to be SGA compared to children from the referent group. They were also less likely to have a high birthweight (≥4000 g).
Excluding pregnancies with missing data on gestational age, resulted in a distribution of gestational age and birthweight categories more similar to those from national statistics. Reassuringly, the findings relating to HG, however, showed very similar relative odds for adverse neonatal outcomes to the overall analysis (Table S1 ).
Comment
Principal findings
We assessed the risk of adverse maternal, delivery, and birth outcomes in women with one or more hospital admissions with a primary diagnosis of HG using the full inpatient hospital records dataset for England (HES) collected from 1997 to 2012. Within a cohort of over 8 million pregnancies we found that hospital admission for HG was associated with a relative increase of developing anaemia, preeclampsia and eclampsia, hypertension during pregnancy and DVT and PE antenatally, at delivery and up to 12 weeks post-partum. Women with HG admissions were more likely to be induced, have a caesarean section and deliver preterm. Although the relative odds of stillbirth was reduced for women with HG admissions, their babies were more likely to be small-for-gestational-age and have low birthweight.
Interpretation
Whilst a general association between HG and preeclampsia has been previously reported, 24 another large study 8 found that women with a first admission for HG in the second trimester were more likely to develop preeclampsia. We found that this association was true also for eclampsia and for both HG admission and readmission, regardless of the time of admission. Although we had no evidence that HG is responsible for minor placental dysfunctions, it could be an early warning of severe problems associated with placental function such as eclampsia or the two conditions could share a common aetiology reflecting for instance different aspects of faulty immunology of pregnancy. The Royal College of Obstetricians and Gynaecologists' (RCOG) green-top guidelines consider HG a transient risk factor for VTE 25 according to evidence of a general increased risk of VTE for women with HG. 7, 26 However, whilst a higher VTE risk during the antepartum period and at delivery was confirmed in other studies, 7, 12 evidence for VTE in the post-partum period alone was not reported.
12,13
Whilst the absolute risk was very small, in our study women with HG showed a higher relative odds of VTE antenatally, at delivery and up to 12 weeks post-partum for both DVT and PE. This could be due to an antepartum DVT either diagnosed only postnatally or causing a later post-partum PE. Clinical reviews and previous studies 1, 27 have shown anaemia as a likely consequence of HG due to malnutrition and this was confirmed by our results. The current largest study on the topic so far 14 showed an inverse association with LGA (OR 0.95, 95% CI 0.90, 0.99), in agreement with our results (OR 0.97, 99% CI 0.93, 0.99 and OR 0.92, 99% CI 0.87, 0.98, respectively) although we found a positive association with very preterm birth, in contrast with their results. In addition, we showed an increased relative odds of SGA especially for HG readmission, as confirmed by other studies. 8, 17 We found HG to be significantly associated with preterm birth and low birthweight, which was also confirmed in a previous systematic review. 17 Of the very few studies that have looked into the risk of stillbirth for women with HG, lack of statistical power was a common limitation even for the largest of these. 9, 10, 14 In contrast, our study population size allowed us to show an inverse association with stillbirth in agreement only with a previous study from 1985. 28 This finding is somewhat counter-intuitive; the risk of SGA is increased in women with HG (probably due to placental dysfunction or maternal nutritional deficits), and SGA is known to be one of the main causes of stillbirth. 29 A possible explanation is that the increased rate of spontaneous and elective preterm deliveries among women with HG outweighs this effect, such that the children at the greatest risk of stillbirth if carried to term are typically delivered before they become fatally malnourished, leading to a HG, Hyperemesis Gravidarum. Pregnancies are defined as HG admission if there was only one hospital admission with primary diagnosis of HG in the current pregnancy or HG readmission if there was more than one hospital admission in the current pregnancy. aOR, adjusted conditional odds ratio from multinomial logistic regression other than for gestational anaemia, diabetes, and hypertension where binary logistic regression was used; see Table 1 for model covariate adjustments. Baseline comparions for all models are pregnancies with no HG admission. CI, confidence interval. a Not adjusted for hypercholesterolaemia due to lack of variability.
lower risk of stillbirth overall. We did not find any association between HG and gestational diabetes and contrasting results are reported in previous studies.
9-11
HG was not a risk factor for gestational hypertension in previously published work, 9,10 in contrast with our results showing higher effect estimates for HG readmission. Higher rates of induction of labour and caesarean section have been demonstrated previously in women with HG, 30 in agreement with our results;
however, for the nature of our data we were unable to establish why these medical interventions were chosen by the doctor. Children born to mothers with HG were also more likely to need neonatal care and/or resuscitation although the absolute increased risks were low; this is to our knowledge the first study to look into these specific adverse outcomes. Strengths of the study
To our knowledge this work represents the largest study so far carried out on this topic. The quality of the HES dataset has improved over time 31 and its validity has been demonstrated in different studies including in the area of perinatal epidemiology. 3, 21 Over 97% of deliveries in England and Wales in the 1997-2011 time window took place in National Health Service (NHS), maternity units, and maternity wings 32 and all delivery information is recorded in inpatient data. Moreover, in the UK, all women are offered free antenatal care and entitled to free NHS prescriptions during pregnancy, therefore, we believe that our population capture the vast majority of pregnant women in England. The data are comprehensive, nationally representative, 21, 25, [33] [34] [35] and prospectively recorded so free from recall bias. The size of our population and the assessment of significance at the 1% level reduce the possibility that results were due to chance alone.
Limitations of the data
Although data on some possible confounding factors, such as smoking or body mass index (BMI), weight loss or treatment, were not available, information on a large number of other basic demographic characteristics and common comorbidities allowed for a robust adjustment for important confounders. Hospital data will miss milder complications, such as mild anaemia for which women are not admitted to hospital. The prevalence of hypertension and diabetes was on the lower range of those reported in the literature. 36, 37 However, we would expect maternity HES data to capture significant acute morbidity such as VTE cases which are treated in secondary care in the UK. 7, 13 Where gestation data were missing a multiple imputation was applied, however, we also conducted a sensitivity analysis excluding pregnancies of unknown length and results were similar to the original analysis. The amount of missing data for other variables was generally low apart from specific birth outcomes such as resuscitation and neonatal care. However, the sensitivity analysis showed unchanged results with a much lower missing value rate (2% missing for birthweight and 6.4% for SGA in the highest prevalence group).
We assessed HG readmission as a way of assessing severity, though we acknowledge that the probability of being readmitted could be influenced by other factors, such as external support or sociocultural factors, not available from this data source.
The current largest study on the topic, 14 based on the Medical Birth Registry of Norway (MBRN), a validated dataset for epidemiological research, 38 includes all births in Norway, compared with an estimated 97% of English births included in HES. The Norwegian study had information on maternal smoking, which is not available in HES, however, MBRN has been reported to underestimate cases of severe HG due to a codification change to less specific codes for data recorded from 1999. 39 It also does not include details such as onset an duration of HG. It is likely that we have captured a good estimation of the starting time of this condition and a potential duration according to the dates of hospital admissions in the HES data. On the other hand, our study is based only on hospital admission for HG, which will skew the analysis towards the higher level of HG severity, excluding women who may only consult their GP or midwife, or obtain private support.
Conclusions
HG is associated with adverse health outcomes for the affected mother and child. Although for certain outcomes such as preeclampsia or VTE the absolute increased risks are low, HG can represent a warning sign of possible imminent complications, such as anaemia or dehydration. Recognition of early symptoms of HG and improvement in provision of timely support to women at high risk could help prevent and control complications such as anaemia, or VTE secondary to dehydration. Future research should assess effects of different treatments for HG offered in primary or secondary care settings on adverse pregnancy and birth outcomes, considering the low-quality evidence currently available. 40 
